News
HONG KONG, China I August 4, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its global, multicenter, randomized Phase II ...
TAIPEI, Taiwan I August 4, 2025 I Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback